Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in

Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa

Listen now

Description

Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa. Read the full article: Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials

More Episodes

See all »

Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana

Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana) on Botswana´s accomplishments and progress towards achieving the UNAIDS 95...

Published 04/09/24

The Lancet HIV in conversation with

Published 04/09/24

Adam Trickey on trends in causes of death among people with HIV in Europe and North America

Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America. Read the full...

Published 02/27/24